Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Retractable Rejected by Top Court on Becton Patent Appeal

The U.S. Supreme Court rejected an appeal by Retractable Technologies Inc. in its patent suit against Becton, Dickinson & Co. over technology used to protect health-care workers from accidental needle sticks.

Retractable was seeking to overturn a federal appeals court decision that struck down part of a $5 million jury award.

The U.S. Court of Appeals for the Federal Circuit ruled in July that Becton’s 3-milliliter Integra syringe doesn’t violate Retractable’s patents. The appeals court upheld the jury’s separate finding against Becton over its 1-milliliter Integra product. The patents cover Retractable’s VanishPoint-brand syringes, which contain spring-loaded needles.

Retractable, based in Little Elm, Texas, is also pressing an antitrust case against Becton, based in Franklin Lakes, New Jersey.

The case is Retractable Technologies v. Becton Dickinson, 11-1154.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.